Efficacy and safety of pateclizumab (anti-lymphotoxin-α) compared to adalimumab in rheumatoid arthritis: a head-to-head phase 2 randomized controlled study (The ALTARA Study)

Overview of attention for article published in Arthritis Research & Therapy, October 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

So far, Dimensions has found 37 publications that cite this research output.

Article in Nature Reviews Rheumatology (August 2023)

Article in Frontiers in Immunology (July 2023)

Article in Current Rheumatology Reviews (January 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.